- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05526365
Idea Density in Exam Performance (IDEP)
Impact of Reduced Idea Density on Pharmacy Students' Attainment in Pharmaceutical Calculations: a Single-blind Multicentre Randomised Controlled Trial
Text can be written in multiple ways to mean the same thing; changing how a text is written can make it easier or harder to understand. How many concepts or ideas there are in a text, divided by the total number of words, is one possible way to determine how easy or hard it is to understand. This ratio is called idea density (ID).
Varying ID has been shown to affect the speed at which a reader understands; it impacts certain people more than others, such as second language speakers. This effect may be of particular importance in an exam, where understanding a question in a limited time is key. In the UK, pharmacy students must undertake an exam set by the General Pharmaceutical Council (GPhC) to be registered as pharmacists. The exam involves pharmaceutical calculations and shows variable pass rates. This study aims to evaluate the impact of reducing ID in a pharmaceutical calculation test and will be conducted in 14 schools of pharmacy in the UK. All participants will take a GPhC style test. Then, participants will be divided into two groups of equal size; one group will undertake a second test with the same ID as the first, while the second group will undertake a test with a lower ID. Finally, the investigators will compare the second test scores between the two groups as cohorts and question by question, evaluating whether lowering ID has increased students' scores.
If and effect is seen, ensuring that questions are written with a controlled ID may help ensure we are examining more fairly and allowing students with the requisite knowledge to pass.
Study Overview
Status
Intervention / Treatment
Detailed Description
Pharmaceutical Council must be undertaken. It involves pharmaceutical calculations and shows variable pass rates. Linguistic factors, such as idea density, affect and predict comprehension time. This trial will evaluate the effect of lowering question idea density on attainment in a pharmaceutical calculations exam aligned to that of the General Pharmaceutical Council.
Methods: This is a single-blind, parallel 2-arm multicentre randomised controlled trial conducted in fourteen Universities across the United Kingdom. A 1:1 randomisation and a sample size of 188 pharmacy students will be sufficient to detect a 1-point difference in the mean scores between the intervention and control group during a pharmacy calculation test with two-tails, 80% power and 5% significance level. Each school will recruit a minimum of 14/15 students. Participants will sit two 12-question pharmaceutical calculation tests. All participants will take the same baseline test; then, will be randomised and undertake a second test 2-week after, with standard idea density for the control group and lower idea density for the intervention. Primary outcome: the scores obtained by the participants undertaking the second calculation test 2-week after the baseline. Secondary outcomes: percentage of students achieving a pass during the second test; effect of demographic characteristics (first or not-first English language speakers, age, ethnicity, year of study, specific learning disability) on participants' attainment when lowering idea density.
Conclusion: Results could inform the development of new standards in the pharmaceutical calculations exam.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mandy Williams
- Phone Number: 6467 01519046467
- Email: A.F.Williams@ljmu.ac.uk
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L3 3AF
- Liverpool John Moores University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Over 18 years of age
- Registered as a student on an MPharm course in the UK
- Be in years 1-4 of the course (levels 1-7)
Exclusion Criteria:
- Under 18
- Not registered on an MPharm course in the UK
- Are currently undertaking a foundation year (level 3)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Participants in the control group will receive an initial 12 question baseline test (same as intervention).
They will after two weeks receive a second test that is linguistically the same as the national GPhC exam.
|
|
Experimental: Intervention
Participants in the intervention group will receive an initial 12 question baseline test (same as control).
They will after two weeks receive a second test that is reduced in idea density by around 10% overall.
|
Question idea density reduced (ratio of propositions to total words used).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall performance on test 2
Time Frame: 1 month
|
The primary outcome is the performance in the second calculation test 2. Overall score per student can be between 0-12, and performance of all students on each question a decimal percent between 0-1, with 0 meaning 0% of students answered correctly and 1 meaning 100% of students answered correctly.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pass rate
Time Frame: 1 month
|
The percentage of students achieving a pass (equivalent to 70% or above) during the second test.
|
1 month
|
Demographic
Time Frame: 1 month
|
The effect of each demographic characteristic on students' attainment in pharmacy calculation when lowering idea density?
|
1 month
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 22/PBS/004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Education
-
Sakarya UniversityRecruiting
-
Harvard University Faculty of MedicineCompletedProblem-based Learning | Education, Medical | Problem Solving | Education, Medical, Undergraduate | Interactive TutorialUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingEducation, Medical | Venous Puncture | Students, MedicalChina
-
National Taiwan University HospitalNot yet recruitingEducation, MedicalTaiwan
-
National Taiwan University HospitalRecruitingEducation, MedicalTaiwan
-
Copenhagen Academy for Medical Education and SimulationCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Universidad Autonoma de Nuevo LeonCompleted
-
Children's Hospital of PhiladelphiaAmerican Academy of Pediatrics Section of Neonatal-Perinatal Medicine; Organization...Completed
-
Yonsei UniversityTerminatedMedical EducationKorea, Republic of
Clinical Trials on Reduced Idea Density
-
IDEA AGCompleted
-
IDEA AGCompletedJoint Pain | Musculoskeletal Pain | Stiffness | Soft Tissue Inflammation in Designated Target Area(s)Germany
-
National Institute of Diabetes and Digestive and...Completed
-
IDEA AGCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Hospital del Mar Research Institute (IMIM)Parc de Salut Mar; Instituto de Salud Carlos IIIRecruitingDepressive Disorder | Depressive SymptomsSpain
-
DoubleGood ABLund University; Aventure ABCompleted
-
IDEA AGCompletedOsteoarthritis, KneeUnited States
-
University of PennsylvaniaTerminatedAtherosclerotic PlaqueUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed